Literature DB >> 8866177

Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma.

M Perrin-Fayolle1, P S Blum, J Morley, M Grosclaude, M T Chambe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8866177     DOI： 10.1007/BF02772208

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  33 in total

Review 1.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

2.  SElectivity of broncholidlator action of salbutamol in asthmatic patients.

Authors:  J W Paterson; R J Evans; F J Prime
Journal:  Br J Dis Chest       Date:  1971-01

3.  Asthma induced by adrenergic aerosols.

Authors:  R E Reisman
Journal:  J Allergy       Date:  1970-09

4.  Bronchodilators and bronchial hyperresponsiveness.

Authors:  D R Taylor; M R Sears
Journal:  Thorax       Date:  1994-02       Impact factor: 9.139

5.  Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.

Authors:  J Grainger; K Woodman; N Pearce; J Crane; C Burgess; A Keane; R Beasley
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

6.  Paradoxic bronchospasm after inhalation of isoptroterenol.

Authors:  J Trautlein; J Allegra; J Field; M Gillin
Journal:  Chest       Date:  1976-12       Impact factor: 9.410

7.  Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.

Authors:  U K Walle; G R Pesola; T Walle
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

8.  The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.

Authors:  E H Bel; A H Zwinderman; M C Timmers; J H Dijkman; P J Sterk
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

9.  Some observations on the -adrenoceptor agonist properties of the isomers of salbutamol.

Authors:  R T Brittain; J B Farmer; R J Marshall
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

10.  Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine.

Authors:  E T Peel; G J Gibson
Journal:  Am Rev Respir Dis       Date:  1980-06
View more
  5 in total

Review 1.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 2.  Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

Authors:  Glenn A Jacobson; Sharanne Raidal; Morten Hostrup; Luigino Calzetta; Richard Wood-Baker; Mark O Farber; Clive P Page; E Haydn Walters
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

3.  Prescribing trends with levalbuterol (xopenex) at a community hospital.

Authors:  Nicole D Verkleeren; Krista M Lipchick
Journal:  P T       Date:  2009-10

4.  Levalbuterol versus albuterol.

Authors:  Bill T Ameredes; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2009-09       Impact factor: 4.806

5.  Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.

Authors:  M G Arroyo; L L Couëtil; N Nogradi; M M Kamarudin; K M Ivester
Journal:  J Vet Intern Med       Date:  2016-06-09       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.